Characterization and Probiotic Potential of <i>Levilactobacillus brevis</i> DPL5: A Novel Strain Isolated from Human Breast Milk with Antimicrobial Properties Against Biofilm-Forming <i>Staphylococcus aureus</i>

Lactobacillus is a key genus of probiotics commonly utilized for the treatment of oral infections The primary aim of our research was to investigate the probiotic potential of the newly isolated <i>Levilactobacillus brevis</i> DPL5 strain from human breast milk, focusing on its ability t...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivan Iliev, Galina Yahubyan, Elena Apostolova-Kuzova, Mariyana Gozmanova, Daniela Mollova, Iliya Iliev, Lena Ilieva, Mariana Marhova, Velizar Gochev, Vesselin Baev
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/13/1/160
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587870200659968
author Ivan Iliev
Galina Yahubyan
Elena Apostolova-Kuzova
Mariyana Gozmanova
Daniela Mollova
Iliya Iliev
Lena Ilieva
Mariana Marhova
Velizar Gochev
Vesselin Baev
author_facet Ivan Iliev
Galina Yahubyan
Elena Apostolova-Kuzova
Mariyana Gozmanova
Daniela Mollova
Iliya Iliev
Lena Ilieva
Mariana Marhova
Velizar Gochev
Vesselin Baev
author_sort Ivan Iliev
collection DOAJ
description Lactobacillus is a key genus of probiotics commonly utilized for the treatment of oral infections The primary aim of our research was to investigate the probiotic potential of the newly isolated <i>Levilactobacillus brevis</i> DPL5 strain from human breast milk, focusing on its ability to combat biofilm-forming pathogens such as <i>Staphylococcus aureus</i>. Employing in vitro approaches, we demonstrate <i>L. brevis</i> DPL5′s ability to endure at pH 3 with survival rates above 30%, and withstand the osmotic stress often found during industrial processes like fermentation and freeze drying, retaining over 90% viability. The lyophilized cell-free supernatant of <i>L. brevis</i> DPL5 had a significant antagonistic effect against biofilm-producing nasal strains of <i>Staphylococcus aureus</i>, and it completely eradicated biofilms at subinhibitory concentrations of 20 mg·mL<sup>−1</sup>. Higher concentrations of 69 mg·mL<sup>−1</sup> were found to have a 99% bactericidal effect, based on the conducted probability analysis, indicating the production of bactericidal bioactive extracellular compounds capable of disrupting the biofilm formation of pathogens like <i>S. aureus</i>. Furthermore, genome-wide sequencing and analysis of <i>L. brevis</i> DPL5 with cutting-edge Nanopore technology has uncovered over 50 genes linked to probiotic activity, supporting its ability to adapt and thrive in the harsh gut environment. The genome also contains multiple biosynthetic gene clusters such as lanthipeptide class IV, Type III polyketide synthase (T3PKS), and ribosomally synthesized, and post-translationally modified peptides (RiPP-like compounds), all of which are associated with antibacterial properties. Our study paves the way for the further exploration of DPL5, setting the stage for innovative, nature-inspired solutions to combat stubborn bacterial infections.
format Article
id doaj-art-a0f7e3e3ff944e27bbdc35cc864614c3
institution Kabale University
issn 2076-2607
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj-art-a0f7e3e3ff944e27bbdc35cc864614c32025-01-24T13:42:52ZengMDPI AGMicroorganisms2076-26072025-01-0113116010.3390/microorganisms13010160Characterization and Probiotic Potential of <i>Levilactobacillus brevis</i> DPL5: A Novel Strain Isolated from Human Breast Milk with Antimicrobial Properties Against Biofilm-Forming <i>Staphylococcus aureus</i>Ivan Iliev0Galina Yahubyan1Elena Apostolova-Kuzova2Mariyana Gozmanova3Daniela Mollova4Iliya Iliev5Lena Ilieva6Mariana Marhova7Velizar Gochev8Vesselin Baev9Department of Biochemistry and Microbiology, Faculty of Biology, University of Plovdiv, Tzar Assen 24, 4000 Plovdiv, BulgariaDepartment of Molecular Biology, Faculty of Biology, University of Plovdiv, Tzar Assen 24, 4000 Plovdiv, BulgariaDepartment of Molecular Biology, Faculty of Biology, University of Plovdiv, Tzar Assen 24, 4000 Plovdiv, BulgariaDepartment of Molecular Biology, Faculty of Biology, University of Plovdiv, Tzar Assen 24, 4000 Plovdiv, BulgariaDepartment of Biochemistry and Microbiology, Faculty of Biology, University of Plovdiv, Tzar Assen 24, 4000 Plovdiv, BulgariaDepartment of Biochemistry and Microbiology, Faculty of Biology, University of Plovdiv, Tzar Assen 24, 4000 Plovdiv, BulgariaDepartment of Biochemistry and Microbiology, Faculty of Biology, University of Plovdiv, Tzar Assen 24, 4000 Plovdiv, BulgariaDepartment of Biochemistry and Microbiology, Faculty of Biology, University of Plovdiv, Tzar Assen 24, 4000 Plovdiv, BulgariaDepartment of Biochemistry and Microbiology, Faculty of Biology, University of Plovdiv, Tzar Assen 24, 4000 Plovdiv, BulgariaDepartment of Molecular Biology, Faculty of Biology, University of Plovdiv, Tzar Assen 24, 4000 Plovdiv, BulgariaLactobacillus is a key genus of probiotics commonly utilized for the treatment of oral infections The primary aim of our research was to investigate the probiotic potential of the newly isolated <i>Levilactobacillus brevis</i> DPL5 strain from human breast milk, focusing on its ability to combat biofilm-forming pathogens such as <i>Staphylococcus aureus</i>. Employing in vitro approaches, we demonstrate <i>L. brevis</i> DPL5′s ability to endure at pH 3 with survival rates above 30%, and withstand the osmotic stress often found during industrial processes like fermentation and freeze drying, retaining over 90% viability. The lyophilized cell-free supernatant of <i>L. brevis</i> DPL5 had a significant antagonistic effect against biofilm-producing nasal strains of <i>Staphylococcus aureus</i>, and it completely eradicated biofilms at subinhibitory concentrations of 20 mg·mL<sup>−1</sup>. Higher concentrations of 69 mg·mL<sup>−1</sup> were found to have a 99% bactericidal effect, based on the conducted probability analysis, indicating the production of bactericidal bioactive extracellular compounds capable of disrupting the biofilm formation of pathogens like <i>S. aureus</i>. Furthermore, genome-wide sequencing and analysis of <i>L. brevis</i> DPL5 with cutting-edge Nanopore technology has uncovered over 50 genes linked to probiotic activity, supporting its ability to adapt and thrive in the harsh gut environment. The genome also contains multiple biosynthetic gene clusters such as lanthipeptide class IV, Type III polyketide synthase (T3PKS), and ribosomally synthesized, and post-translationally modified peptides (RiPP-like compounds), all of which are associated with antibacterial properties. Our study paves the way for the further exploration of DPL5, setting the stage for innovative, nature-inspired solutions to combat stubborn bacterial infections.https://www.mdpi.com/2076-2607/13/1/160<i>Levilactobacillus brevis</i><i>Staphylococcus aureus</i>LABgenome sequencingprobiotic and anti-biofilm capacity
spellingShingle Ivan Iliev
Galina Yahubyan
Elena Apostolova-Kuzova
Mariyana Gozmanova
Daniela Mollova
Iliya Iliev
Lena Ilieva
Mariana Marhova
Velizar Gochev
Vesselin Baev
Characterization and Probiotic Potential of <i>Levilactobacillus brevis</i> DPL5: A Novel Strain Isolated from Human Breast Milk with Antimicrobial Properties Against Biofilm-Forming <i>Staphylococcus aureus</i>
Microorganisms
<i>Levilactobacillus brevis</i>
<i>Staphylococcus aureus</i>
LAB
genome sequencing
probiotic and anti-biofilm capacity
title Characterization and Probiotic Potential of <i>Levilactobacillus brevis</i> DPL5: A Novel Strain Isolated from Human Breast Milk with Antimicrobial Properties Against Biofilm-Forming <i>Staphylococcus aureus</i>
title_full Characterization and Probiotic Potential of <i>Levilactobacillus brevis</i> DPL5: A Novel Strain Isolated from Human Breast Milk with Antimicrobial Properties Against Biofilm-Forming <i>Staphylococcus aureus</i>
title_fullStr Characterization and Probiotic Potential of <i>Levilactobacillus brevis</i> DPL5: A Novel Strain Isolated from Human Breast Milk with Antimicrobial Properties Against Biofilm-Forming <i>Staphylococcus aureus</i>
title_full_unstemmed Characterization and Probiotic Potential of <i>Levilactobacillus brevis</i> DPL5: A Novel Strain Isolated from Human Breast Milk with Antimicrobial Properties Against Biofilm-Forming <i>Staphylococcus aureus</i>
title_short Characterization and Probiotic Potential of <i>Levilactobacillus brevis</i> DPL5: A Novel Strain Isolated from Human Breast Milk with Antimicrobial Properties Against Biofilm-Forming <i>Staphylococcus aureus</i>
title_sort characterization and probiotic potential of i levilactobacillus brevis i dpl5 a novel strain isolated from human breast milk with antimicrobial properties against biofilm forming i staphylococcus aureus i
topic <i>Levilactobacillus brevis</i>
<i>Staphylococcus aureus</i>
LAB
genome sequencing
probiotic and anti-biofilm capacity
url https://www.mdpi.com/2076-2607/13/1/160
work_keys_str_mv AT ivaniliev characterizationandprobioticpotentialofilevilactobacillusbrevisidpl5anovelstrainisolatedfromhumanbreastmilkwithantimicrobialpropertiesagainstbiofilmformingistaphylococcusaureusi
AT galinayahubyan characterizationandprobioticpotentialofilevilactobacillusbrevisidpl5anovelstrainisolatedfromhumanbreastmilkwithantimicrobialpropertiesagainstbiofilmformingistaphylococcusaureusi
AT elenaapostolovakuzova characterizationandprobioticpotentialofilevilactobacillusbrevisidpl5anovelstrainisolatedfromhumanbreastmilkwithantimicrobialpropertiesagainstbiofilmformingistaphylococcusaureusi
AT mariyanagozmanova characterizationandprobioticpotentialofilevilactobacillusbrevisidpl5anovelstrainisolatedfromhumanbreastmilkwithantimicrobialpropertiesagainstbiofilmformingistaphylococcusaureusi
AT danielamollova characterizationandprobioticpotentialofilevilactobacillusbrevisidpl5anovelstrainisolatedfromhumanbreastmilkwithantimicrobialpropertiesagainstbiofilmformingistaphylococcusaureusi
AT iliyailiev characterizationandprobioticpotentialofilevilactobacillusbrevisidpl5anovelstrainisolatedfromhumanbreastmilkwithantimicrobialpropertiesagainstbiofilmformingistaphylococcusaureusi
AT lenailieva characterizationandprobioticpotentialofilevilactobacillusbrevisidpl5anovelstrainisolatedfromhumanbreastmilkwithantimicrobialpropertiesagainstbiofilmformingistaphylococcusaureusi
AT marianamarhova characterizationandprobioticpotentialofilevilactobacillusbrevisidpl5anovelstrainisolatedfromhumanbreastmilkwithantimicrobialpropertiesagainstbiofilmformingistaphylococcusaureusi
AT velizargochev characterizationandprobioticpotentialofilevilactobacillusbrevisidpl5anovelstrainisolatedfromhumanbreastmilkwithantimicrobialpropertiesagainstbiofilmformingistaphylococcusaureusi
AT vesselinbaev characterizationandprobioticpotentialofilevilactobacillusbrevisidpl5anovelstrainisolatedfromhumanbreastmilkwithantimicrobialpropertiesagainstbiofilmformingistaphylococcusaureusi